The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue 1, 2012, Pages 104-108

  Guneri, Enis Alpin ^a   Kustutan, Ozge ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Betahistine; Canalithiasis; Epley maneuver; Posterior canal BPPV

Indexed keywords

BETAHISTINE; PLACEBO; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BENIGN PAROXYSMAL POSITIONAL VERTIGO; CANALITHIASIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EMERGENCY TREATMENT; EPLEY MANEUVER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEMICIRCULAR CANAL; STONE FORMATION; TREATMENT OUTCOME; ADOLESCENT; BODY POSTURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYSIOTHERAPY; VERTIGO;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; BETAHISTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; POSTURE; SEMICIRCULAR CANALS; TREATMENT OUTCOME; VASODILATOR AGENTS; VERTIGO; YOUNG ADULT;

EID: 84857173984     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811419093     Document Type: Article

References (37)

1. Oghalai JS. Unrecognized benign paroxysmal positional vertigo in elderly patients. Otolaryngol Head Neck Surg. 2000;122:630-634. (Pubitemid 30333836)
2. von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78:710-715. (Pubitemid 46998841)
3. Schuknecht HF, Ruby RR. Cupulolithiasis. Adv Otorhinolaryngol. 1973;20:434-443.
4. Guneri EA. BPPV: the most common cause of vertigo. İc Hastaliklari Forumu Dergisi. 2010;2:34-45.
5. Otsuka K, Suzuki M, Furuya M. Model experiment of benign paroxysmal positional vertigo mechanism using the whole membranous labyrinth. Acta Otolaryngol. 2003;123:515-518. (Pubitemid 36609770)
6. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 1992;107:399-404.
7. Pollak L, Davies RA, Luxon LL. Effectiveness of the particle repositioning maneuver in benign paroxysmal positional vertigo with and without additional vestibular pathology. Otol Neurotol. 2002;23:79-83. (Pubitemid 34073836)
8. Mira E, Guidetti G, Ghilardi L, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol. 2003;260:73-77. (Pubitemid 36286860)
9. Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otolaryngol Ital. 2006;26:208-215.
10. Nunez RA, Cass SP, Furman JM. Short and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2000;122:647-652. (Pubitemid 30333839)
11. Dornhoffer JL, Colvin GB. Benign paroxysmal positional vertigo and canalith repositioning: clinical correlations. Am J Otolaryngol. 2000;21:230-233. (Pubitemid 30137080)
12. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2004;(2):CD003162.
13. Cavaliere M, Mottola G, Iemma M. Benign paroxysmal positional vertigo: a study of two maneuvers with and without betahistine. Acta Otolaryngol Ital. 2005;25:107-112.
14. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez- Fiñana M. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2005;262:507-511. (Pubitemid 40909631)
15. Korres S, Balatsouras DG, Ferekidis E. Prognosis of patients with benign paroxysmal positional vertigo treated with repositioning maneuvers. J Laryngol Otol. 2006;120:528-533. (Pubitemid 44197018)
16. Riis P. Perspectives on the fifth revision of the Declaration of Helsinki. JAMA. 2000;284:3045-3046. (Pubitemid 32014744)
17. Whitney SL, Marchetti GF, Morris LO. Usefulness of the dizziness handicap inventory in the screening for benign paroxysmal positional vertigo. Otol Neurootol. 2005;26:1027-1033. (Pubitemid 41330723)
18. Treleaven J. Dizziness Handicap Inventory (DHI). Aust J Physiother. 2006;52:67-68.
19. Cohen H, Kimball KT. Development of the vestibular disorders activities of daily living scale. Arch Otol Head Neck Surg. 2000;126:881-887. (Pubitemid 30460658)
20. Megnigbeto C, Sauvage JP, Laurois R. The European Evaluation of Vertigo Scale (EEV): a clinical validation study. Rev Laryngol Otol Rhinol (Bord). 2001;122:95-102. (Pubitemid 32995012)
21. Wilhelmsen K, Strand L, Nordahl SH, Eide GE. Psychometric properties of the Vertigo Symptom Scale-Short Form. BMC Ear Nose Throat Disord. 2008;8:2.
22. Yanik B, Kulcu DG, Kurtais Y, Boynukalin S. The reliability and validity of the Vertigo Symptom Scale and the Vertigo Dizziness Imbalance Questionnaires in a Turkish patient population with benign paroxysmal positional vertigo. J Vestib Res. 2008;18:159-170.
23. Steenerson RL, Cronin GW. Comparison of canalith repositioning procedure and vestibular habituation training in forty patients with benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 1996;114:61-64. (Pubitemid 26044410)
24. Gross EM, Ress BD, Viirre ES, Nelson JR. Intractable benign paroxysmal positional vertigo in patients with Meniere disease. Laryngoscope. 2000;110:655-659. (Pubitemid 30198722)
25. Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109:377-380. (Pubitemid 30198528)
26. Lynn S, Pool A, Rose D, Brey R. Randomized trial of the canalith repositioning procedure. Otolaryngol Head Neck Surg. 1995;113:712-720. (Pubitemid 26001279)
27. Hilton M, Pinder D. The Epley maneuver for benign paroxysmal positional vertigo: a systematic review. Clin Otolaryngol Allied Sci. 2002;27:440-445. (Pubitemid 36042864)
28. White J, Savvides P, Cherian N, Oas J. Canalith repositioning for benign paroxysmal positional vertigo. Otol Neurotol. 2005;26:704-710. (Pubitemid 41026101)
29. Helminski JO, Zee DS, Janssen I, Hain TC. Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic review. Phys Ther. 2010;90:663-678.
30. Mendel B, Bergenius J, Langius A. Dizziness symptom severity and impact on daily living as perceived by patients suffering from peripheral vestibular disorder. Clin Otolaryngol Allied Sci. 1999;24:286-293. (Pubitemid 29397098)
31. Kulcu DG, Yanik B, Boynukalin S, Kurtais Y. Efficacy of a home based exercise program on benign paroxysmal positional vertigo compared with betahistine. J Otolaryngol Head Neck Surg. 2008;37:373-379.
32. Fujino A, Tokumasu K, Okamoto M, Naganuma H. Vestibular training for acute unilateral vestibular disturbances: its efficacy in comparison with antivertigo drug. Acta Otolaryngol. 1996; 524:21-26. (Pubitemid 26186216)
33. Dziadziola JK, Laurikainen EL, Rachel JD, Quirk WS. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg. 1999;120:400-405. (Pubitemid 29135878)
34. Laurikainen E, Miller JM, Nuttall AL, Quirk WS. The vascular mechanism of action of betahistine in the ear of the guinea pig. Eur Arch Otolaryngol. 1998;255:119-123. (Pubitemid 28171152)
35. Soto E, Chavez H, Vali P, Benvenuti C, Vega R. Betahistine produces post-synaptic inhibition of the excitability of the primary afferent neurons in the vestibular endorgans. Acta Otolaryngol. 2001;545:19-24. (Pubitemid 32964374)
36. Honrubia V, Bell TS, Harris MR, Baloh RW, Fisher LM. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol. 1996;17:595-602. (Pubitemid 26254914)
37. Duracinsky M, Mosnier I, Bouccara D, Sterkers O. Literature review of dizziness and their impact on patients' quality of life. Value Health. 2007;10:273-284. (Pubitemid 47077252)